L Degos

Letter: Histocompatibility determinants in multiple sclerosis.

J Dausset, J. Dausset, L. Degos, 1974, Lancet.

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia.

H. de Thé, Z. Wang, M. Koken, 1997, Proceedings of the National Academy of Sciences of the United States of America.

All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.

H. de Thé, C. Chomienne, L. Degos, 1991, The Journal of clinical investigation.

The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias.

A. Dejean, P. Fenaux, C. Chomienne, 1990, Leukemia.

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

R Berger, R. Berger, P. Fenaux, 1990, Blood.

Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy

X Thomas, F. Sigaux, J. Cayuela, 2002, Leukemia.